The contribution of endothelin-1 (ET-1), acting via endothelin-A receptors (ET A ), on post-incisional pain was examined in a rat model of incision through the hairy skin of the lumbar dorsum. Post-incisional mechanical hyperesthesia was evaluated by cutaneous trunci muscle reflexes (CTMR) of subcutaneous muscles responding to stimulation with von Frey filaments near the wound (primary responses) and at a distance, especially on the contralateral dorsum (secondary responses, involving spinal circuits). The role of ET A was determined by pre-incisional, subcutaneous injection of the selective receptor antagonist BQ-123 at the incision site, 15 min or 24 h before surgery. Control incisions showed both primary tactile allodynia and hyperalgesia, and a weaker secondary hyperesthesia, peaking 3-4 h after surgery and lasting at least 24 h. Primary allodynia, but not hyperalgesia, was dose-dependently suppressed by 15 min pre-incisional BQ-123. In contrast, both secondary allodynia and hyperalgesia were inhibited by local BQ-123. The suppression of primary allodynia by local antagonist disappeared in 24 h, but that of secondary hyperesthesia remained strong for at least 24 h. Systemically delivered BQ-123 was without effect on any post-incisional hyperesthesia, and if the antagonist was locally injected 24 h before surgery there was no difference on hyperesthesia compared to vehicle injected at that time. We conclude that ET-1, released from skin by incision, activates nociceptors to cause primary allodynia and to sensitize spinal circuits through central sensitization. Blockade of ET A in the immediate peri-operative period prevents the later development of central sensitization. Ó
Introduction
Endothelin-1 (ET-1) is an endogenous peptide of 21 amino acids whose effects are mediated by two G-protein-coupled receptors, ET A and ET B (DeNucci et al., 1988; Lipa et al., 1999; Luscher and Barton, 2000) . ET-1, ET A and ET B receptors (ET A R and ET B R, respectively) all occur in the epidermis, dermis and subcutaneous vasculature (Ahn et al., 1998) . Subcutaneous injection of ET-1 causes pain via ET A R and induces spontaneous impulses in nociceptive cutaneous C-and Ad-fibers (Gokin and Strichartz, 2001 ). ET-1 injections also cause abdominal constrictions in mice and incapacitation of movement of the dog's knee joint (Ferreira et al., 1989; Raffa and Jacoby, 1991) . Furthermore, overproduction of ET-1 is a characteristic of injured skin (Imokawa et al., 1992; Kadono et al., 2001 ), peaking 1-2 days after UV damage and rising after local administration of TNF-a or IL-1a (Imokawa et al., 1992; Ahn et al., 1998; Steinhoff et al., 2003) .
Both C-and Ad-fiber nociceptors amplify inflammation by releasing neuropeptides to target cells, while other cells involved directly in inflammatory processes release cytokines and other mediators (Steinhoff et al., 2003; Pastore et al., 2005) 
